Beximco Pharmaceuticals Limited (AIM:BXP)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 324.38M |
| Revenue (ttm) | 309.11M |
| Net Income (ttm) | 42.38M |
| Shares Out | n/a |
| EPS (ttm) | 0.09 |
| PE Ratio | 7.65 |
| Forward PE | 7.39 |
| Dividend | 0.02 (0.05%) |
| Ex-Dividend Date | Nov 22, 2024 |
| Volume | 28,101 |
| Average Volume | 51,874 |
| Open | 42.70 |
| Previous Close | 43.00 |
| Day's Range | 42.70 - 43.00 |
| 52-Week Range | 28.75 - 52.33 |
| Beta | n/a |
| RSI | 34.58 |
| Earnings Date | Nov 3, 2025 |
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to ... [Read more]
Financial Performance
In 2024, Beximco Pharmaceuticals's revenue was 44.39 billion, an increase of 13.05% compared to the previous year's 39.27 billion. Earnings were 5.83 billion, an increase of 26.34%.
Financial numbers in BDT Financial StatementsNews
Small Cap Stocks: Indus Gas, VAST Resources, Beximco
Indus Gas, VAST Resources, STM Group, Beximco Pharmaceuticals, Gunsynd are the biggest Small Cap stock movers